The report has further categorized the global medical imaging reagents market into different segments based on product type (contrast reagents and nuclear imaging reagents) and geography (the Americas, EMEA, and APAC). It provides a detailed illustration of the major factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Here are some key findings of the global medical imaging reagents market, according to Technavio healthcare and life sciences researchers:
- Rising incidence of cardiovascular disorders and cancer: a major market driver
- In 2016, contrast reagents held the majority share of the global medical imaging reagents market
- The Americas is the largest revenue contributor to the global medical imaging reagents market
- Bayer, Medtronic, Bracco Diagnostics, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging are the key players in the market
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Market growth analysis
One of the key factors driving the global medical imaging reagents market is the rising incidence of cardiovascular disorders and cancer. Globally, there has been an increase in the incidence of cardiovascular diseases (CVDs) such as angina, myocardial infarction, stroke, heart failure, venous thromboembolism, heart arrhythmia, and their associated risk factors. CVDs are expected to cause around 19 million deaths worldwide by 2020. In the European Union (EU), nearly 1.9 million people died due to CVDs in 2013. According to the Centers for Disease Control and Prevention (CDC), around 610,000 people in the US die from heart disease every year.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
According to Technavio researchers, the global medical imaging reagents market in the Americas is predicted to witness high growth rate. The growth is attributed to the rising prevalence of CVDs and cancer, the availability of developed healthcare infrastructure, high healthcare expenditure, and the availability of favorable reimbursements. In the US, reimbursements to the clinicians for low osmolar contrast reagents (LOCAs) are provided by Medicare. The availability of favorable reimbursements has encouraged several patients in countries such as the US to undergo medical diagnostic imaging examinations.
According to Ramakrishna Edupulapati, a lead analyst at Technavio for research on medical imaging, “In the Americas, key vendors such as Lantheus Medical Imaging and GE Healthcare have a strong market presence and a significant proportion of their revenues comes from countries such as the US. These vendors also engage in strategic collaborations and supply agreements to strengthen their presence in the market. In January 2016, Lantheus Medical Imaging entered into a long-term supply and distribution agreement with Isologic Innovative Radiopharmaceuticals to supply its products to Isologic Innovative Radiopharmaceuticals in Canada under certain commercial terms.”
Competitive vendor landscape
A major share of the global medical imaging reagents market is held by key vendors and therefore, the market is highly concentrated. These vendors offer a broad range of products, and possess substantial financial, manufacturing, sales, marketing, and distribution resources. They also make significant investments in R&D and have a strong geographical coverage. Vendors are competing on factors such as price, R&D, quality parameters such as efficacy, product portfolio, regulatory approvals, and distribution networks.
Get a sample copy of the global medical imaging reagents report free of cost
Access Technavio’s continuously growing medical imaging research library and find expert analysis on hundreds of markets.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.